WIF1 and lung cancer: One study among them demonstrated that hypermethylation of WIF-1 (WNT inhibitory factor 1) and IL-12Rbeta2 (Interleukin 12 receptor, beta 2 subunit) promoters commonly arise during the transition of COPD and add the risk for lung cancer development [54].